Welcome! Login | Register
 

Leather Storrs: How TV Influences our Changing Food Culture—Leather Storrs: How TV Influences our Changing Food…

Worcester Night Run to Help Worcester Native in Her Battle Against Cancer—Worcester Night Run 5k on August 28th to…

Worcester Academy Purchases Remaining Land At Former St. Vincent Hospital Property—Worcester Academy has purchased from Boston’s Liberty Properties

Chris Christie Announces Presidential Run—Chris Christie Announces Presidential Run

Paris Hilton Will Perform At The Big E In October—Paris Hilton will close out the 99th edition…

Worcester Will Play A Minor Role In Proposed Boston 2024 Olympics—Boston 2024 has released more than 200 pages…

College Admissions: Will You Get a Free SAT in October?—If you were one of the nearly half…

Fit for Life: Tight Butt. Flat Belly. Great Legs.—“I want a tight butt.” “Flatten my belly.”…

MA Beauty Expert: Summer S.O.S.—Prolific writer Henry James called “summer afternoon” the…

Worcester Youth Leadership Institute Readies For Summer Program—The Worcester Youth Leadership Institute will begin a…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.